• Find People
  • Campus Map
  • PiratePort
  • A-Z
    • About
    • Submit
    • Browse
    • Login
    View Item 
    •   ScholarShip Home
    • Division of Health Sciences
    • Brody School of Medicine
    • Microbiology and Immunology
    • View Item
    •   ScholarShip Home
    • Division of Health Sciences
    • Brody School of Medicine
    • Microbiology and Immunology
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of The ScholarShipCommunities & CollectionsDateAuthorsTitlesSubjectsTypeDate SubmittedThis CollectionDateAuthorsTitlesSubjectsTypeDate Submitted

    My Account

    Login

    Statistics

    View Google Analytics Statistics

    PI3K Isoform Inhibition Associated with Anti Bcr-Abl Drugs Shows in Vitro Increased Anti-leukemic Activity in Philadelphia Chromosome-positive B-acute Lymphoblastic Leukemia Cell Lines

    Thumbnail
    View/ Open
    McCubreyPI3KisoforminhibitionassociatedwithantiBcrAbldrugs.pdf (11.04Mb)

    Show full item record
    
    Author
    McCubrey, James A.
    URI
    http://hdl.handle.net/10342/9623
    Subject
     PI3K isoform inhibition; CT B-acute lymphoblastic leukemia (B-ALL); B-cell progenitor 
    Date
    2017-02-20
    Citation:
    APA:
    McCubrey, James A.. (February 2017). PI3K Isoform Inhibition Associated with Anti Bcr-Abl Drugs Shows in Vitro Increased Anti-leukemic Activity in Philadelphia Chromosome-positive B-acute Lymphoblastic Leukemia Cell Lines. Oncotarget, (8:14), p.23213-23227. Retrieved from http://hdl.handle.net/10342/9623

    Display/Hide MLA, Chicago and APA citation formats.

    MLA:
    McCubrey, James A.. "PI3K Isoform Inhibition Associated with Anti Bcr-Abl Drugs Shows in Vitro Increased Anti-leukemic Activity in Philadelphia Chromosome-positive B-acute Lymphoblastic Leukemia Cell Lines". Oncotarget. 8:14. (23213-23227.), February 2017. May 24, 2022. http://hdl.handle.net/10342/9623.
    Chicago:
    McCubrey, James A., "PI3K Isoform Inhibition Associated with Anti Bcr-Abl Drugs Shows in Vitro Increased Anti-leukemic Activity in Philadelphia Chromosome-positive B-acute Lymphoblastic Leukemia Cell Lines," Oncotarget 8, no. 14 (February 2017), http://hdl.handle.net/10342/9623 (accessed May 24, 2022).
    AMA:
    McCubrey, James A.. PI3K Isoform Inhibition Associated with Anti Bcr-Abl Drugs Shows in Vitro Increased Anti-leukemic Activity in Philadelphia Chromosome-positive B-acute Lymphoblastic Leukemia Cell Lines. Oncotarget. February 2017; 8(14) 23213-23227. http://hdl.handle.net/10342/9623. Accessed May 24, 2022.
    Collections
    • Microbiology and Immunology

    xmlui.ArtifactBrowser.ItemViewer.elsevier_entitlement

    East Carolina University has created ScholarShip, a digital archive for the scholarly output of the ECU community.

    • About
    • Contact Us
    • Send Feedback